Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination

Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain–Barré syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who dev...

Descripción completa

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123983/
https://www.ncbi.nlm.nih.gov/pubmed/34055430
http://dx.doi.org/10.1155/2021/3619131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123983/
https://www.ncbi.nlm.nih.gov/pubmed/34055430
http://dx.doi.org/10.1155/2021/3619131

Ejemplares similares